When it comes to having a bad corporate reputation, it doesn’t get much worse than Insys Therapeutics and Theranos.

Last week, five former Insys executives, including founder John Kapoor, were found guilty of racketeering in pushing the company’s powerful opioid; jurors said they were horrified when they saw a music video, produced to pump up sales, featuring two Insys salesmen rapping about ramping up the dose of the painkiller. Meanwhile, ex-Theranos CEO Elizabeth Holmes and her former No. 2 Sunny Balwani are facing criminal charges for defrauding investors, patients, and physicians about their blood-testing technology; they’re expected to go to trial, perhaps next year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy